MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Treating Depression in Parkinson’s Disease: a Systematic Literature Review

    C. Farrell, T. Yousaf, M. Politis (London, United Kingdom)

    Objective: To elucidate the most acceptable and effective treatments for the management of depression in Parkinson’s disease (PD) using a systematic review approach. Background: Depression…
  • 2019 International Congress

    Associations of microtubule associated protein tau (MAPT) H1 subhaplotypes and the MAPT H2 haplotype with demographic and clinical features in Parkinson`s disease

    A. Deutschlander, M. Heckman, T. Konno, M. Ossi, N. Diehl, A. Soto, A. Strongosky, R. Uitti, J. van Gerpen, O. Ross, W. Zbigniew (Jacksonville, FL, USA)

    Objective: To assess associations of microtubule associated protein tau (MAPT) H1 subhaplotypes and the H2 haplotype with clinical features in patients with Parkinson`s disease (PD).…
  • 2019 International Congress

    Alpha-synuclein promoter (SNCA-Rep1) polymorphism is associated with non-motor symptoms in early Parkinson’s disease

    ASL. Ng, YJ. Tan, Y. Zhao, ZH. Lu, EYL. Ng, SYE. Ng, NSY. Chia, F. Setiawan, ZY. Xu, KY. Tay, WL. Au, EK. Tan, LCS. Tan (Singapore, Singapore)

    Objective: We sought to investigate the relationship between SNCA Rep1 allele length and NMS in PD. Background: Associations between the alpha-synuclein gene (SNCA) promoter region…
  • 2019 International Congress

    The longevity gene Klotho and its CSF protein profiles as modifier for Parkinson´s disease in a longitudinal study

    M. Zimmermann, S. Lerche, C. Schulte, I. Wurster, G. Machetanz, C. Deuschle, A. Hauser, T. Gasser, D. Berg, E. Schleicher, W. Maetzler, K. Brockmann (Tuebingen, Germany)

    Objective: Our objective was to evaluate phenotype modifying effects of variants in longevity genes in PD. Background: Parkinson´s disease (PD) has a large phenotypic variability,…
  • 2019 International Congress

    Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson’s Disease (PDRBD)

    M. Figorilli, P. Pisanu, MG. Mascia, M. Meloni, RM. Lecca, G. Gioi, P. Congiu, L. Tamburrino, G. Defazio, M. Fantini, M. Puligheddu (Monserrato, Italy)

    Objective: We aimed to compare the neuropsychological and psychobehavioral profile of patients with iRBD and PDRBD. Background: REM Sleep Behavior Disorder (RBD) is considered as…
  • 2019 International Congress

    The impact of clinical care coordination on patient quality of life in the Atypical Parkinsonism clinic

    M. Harris, J. Donnelly, L. Massey, B. Ghosh (Southampton, United Kingdom)

    Objective: To assess the impact of clinical care coordination on patient quality of life in the Atypical Parkinsonism clinic. Background: The Atypical Parkinsonian Syndromes of…
  • 2019 International Congress

    Caregiver burden does not improve in the long-term after deep brain stimulation for Parkinson disease

    E. Jackowiak, A. Maher, C. Persad, P. Patil, K. Chou (Ann Arbor, MI, USA)

    Objective: To evaluate if subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson disease (PD) impacts caregiver burden (CB) and to determine which patient factors…
  • 2019 International Congress

    Relationship between parkinsonism and upper extremity function in patients with Parkinson’s disease

    H. Sawada, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)

    Objective: To examine the relationship between upper extremity function and the Movement Disorders Society-Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS-III) for use as a…
  • 2019 International Congress

    Genetics of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) – A Preliminary Demographic profile

    P. Kukkle, V. Goyal, R. Kandadai, R. Borgohain, H. Kumar, A. Mukherjee, A. Biswas, S. Das, U. Muthane, S. Desai, P. Wadia, P. Pal, R. Yadav, V. Ramprasad (Bangalore, India)

    Objective: To see the demographic pattern of Parkinson's Disease (PD) patients of India with onset of clinical symptoms prior to 50 years of age or…
  • 2019 International Congress

    Population Exposure-Response Modeling of the Effects of Apomorphine Sublingual Film on QTc in Patients With Parkinson’s Disease and “OFF” Episodes

    F. Agbo, Y. Chiu, S. Chapel, G. Galluppi, D. Blum, B. Navia (Fort Lee, NJ, USA)

    Objective: To characterize the relationship between plasma apomorphine concentrations and QTc (QT interval corrected for heart rate) in patients with Parkinson’s disease (PD) and “OFF”…
  • « Previous Page
  • 1
  • …
  • 198
  • 199
  • 200
  • 201
  • 202
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley